National, Multicenter, Phase III Prospective Trial About Clinical and Immunological Follow-up After Renal Transplantation in HIV-1 Infected Patients With End Stage Chronic Renal Insufficiency.

Trial Profile

National, Multicenter, Phase III Prospective Trial About Clinical and Immunological Follow-up After Renal Transplantation in HIV-1 Infected Patients With End Stage Chronic Renal Insufficiency.

Completed
Phase of Trial: Phase III

Latest Information Update: 03 May 2017

At a glance

  • Drugs Raltegravir (Primary) ; Antiretrovirals; Immunosuppressants; Mycophenolate mofetil; Tacrolimus
  • Indications Graft-versus-host disease; HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 May 2017 Primary endpoint (Incidence of acute clinical renal graft rejection) has been met, according to the results presented at the 2017 American Transplant Congress
    • 03 May 2017 Results presented at the 2017 American Transplant Congress
    • 11 Jul 2016 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top